These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34235164)

  • 1. Case Report: Hyponatremia Secondary to Desmopressin Administration Prior to Percutaneous Kidney Biopsy: A Case-Based Review.
    Vornicu A; Obrişcă B; Cotruta B; Dulămea AO; Caceaune N; Ismail G
    Front Med (Lausanne); 2021; 8():696904. PubMed ID: 34235164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia.
    Lim CC; Siow B; Choo JCJ; Chawla M; Chin YM; Kee T; Lee PH; Foo M; Tan CS
    Int Urol Nephrol; 2019 Jun; 51(6):995-1004. PubMed ID: 31028561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding Complications and Adverse Events After Desmopressin Acetate for Percutaneous Renal Transplant Biopsy.
    Ho QY; Lim CC; Thangaraju S; Siow B; Chin YM; Hao Y; Lee PH; Foo M; Tan CS; Kee T
    Ann Acad Med Singap; 2020 Feb; 49(2):52-64. PubMed ID: 32246706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal desmopressin reduces renal biopsy-related bleeding and serum sodium levels in patients with reduced renal function.
    Rao NS; Chandra A
    Clin Kidney J; 2020 Dec; 13(6):1063-1067. PubMed ID: 33391750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial.
    Manno C; Bonifati C; Torres DD; Campobasso N; Schena FP
    Am J Kidney Dis; 2011 Jun; 57(6):850-5. PubMed ID: 21354681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Desmopressin Acetate before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Kidney Dysfunction.
    Sethi J; Bansal S; Lal A; Kohli HS; Rathi M
    Indian J Nephrol; 2024; 34(3):228-232. PubMed ID: 39114394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
    MacMillan TE; Tang T; Cavalcanti RB
    Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin Acetate Before Percutaneous Ultrasound-Guided Kidney Biopsy in Patients with Renal Failure - Is it Really Beneficial?
    Jose L; Kaul A; Bhadauria D; Kushwaha R; Nandan R; Lal H; Prasad N; Behera MR; Patel MR
    Indian J Nephrol; 2022; 32(5):430-434. PubMed ID: 36568600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmopressin and bleeding risk after percutaneous kidney biopsy.
    Athavale A; Kulkarni H; Arslan CD; Hart P
    BMC Nephrol; 2019 Nov; 20(1):413. PubMed ID: 31730448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal desmopressin-induced hyponatremia.
    Williford SL; Bernstein SA
    Pharmacotherapy; 1996; 16(1):66-74. PubMed ID: 8700794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of desmopressin administration before kidney biopsy on the risk of major post-biopsy bleeding.
    Cheong M; Lee TY; Lee J; Kim SB
    Nefrologia (Engl Ed); 2022; 42(1):33-40. PubMed ID: 36153897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmopressin Acetate in Percutaneous Ultrasound-Guided Native Kidney Biopsy in Patients with Reduced Kidney Function: A Double-Blind Randomized Controlled Trial.
    Sattari SA; Shahoori A; Shahbazian H; Sabetnia L; Aref A; Sattari AR; Ghorbani A
    Iran J Kidney Dis; 2022 Jul; 16(4):238-245. PubMed ID: 35962638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No effect of desmopressin administration before kidney biopsy on the risk of major post-biopsy bleeding.
    Cheong M; Lee TY; Lee J; Kim SB
    Nefrologia (Engl Ed); 2021 May; ():. PubMed ID: 34052068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Desmopressin Prior to Kidney Biopsy in Patients With High Bleeding Risk.
    Leclerc S; Nadeau-Fredette AC; Elftouh N; Lafrance JP; Pichette V; Laurin LP
    Kidney Int Rep; 2020 Aug; 5(8):1180-1187. PubMed ID: 32775817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin and the risk of hyponatremia: A population-based cohort study.
    Fralick M; Schneeweiss S; Wallis CJD; Jung EH; Kesselheim AS
    PLoS Med; 2019 Oct; 16(10):e1002930. PubMed ID: 31634354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Desmopressin in Hyponatremia: Foe and Friend.
    Achinger SG; Ayus JC
    Kidney Med; 2019; 1(2):65-70. PubMed ID: 32734186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
    Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
    Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors?
    Thumfart J; Roehr CC; Kapelari K; Querfeld U; Eggert P; Müller D
    J Urol; 2005 Jul; 174(1):294-8; discussion 298. PubMed ID: 15947670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodialysis in a young man with severe symptomatic hyponatremia and kidney injury.
    Courteau C; Al Khoury A; Michel RP; Weber CL
    Hemodial Int; 2018 Jul; 22(3):E45-E48. PubMed ID: 29380515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.